Volume 97, Issue 5 pp. E673-E675
CASE REPORT

Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock

Navin K. Kapur MD

Corresponding Author

Navin K. Kapur MD

The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA

Correspondence

Navin K. Kapur, MD, Tufts Medical Center, 800 Washington Street, Box # 80, Boston, MA 02111.

Email: [email protected]

Search for more papers by this author
Colin S. Hirst MD

Colin S. Hirst MD

The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA

Search for more papers by this author
Carlos D. Davila MD

Carlos D. Davila MD

The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA

Search for more papers by this author
Ron Garcia MD

Ron Garcia MD

The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA

Search for more papers by this author
First published: 25 June 2020
Citations: 5

Abstract

Use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is growing exponentially for cardiogenic shock and cardiac arrest, and many of these patients require percutaneous coronary intervention (PCI). In some cases, radial arterial access may not feasible among patients with peripheral vascular disease or if larger diameter guide catheters are required. Further, VA-ECMO is commonly used in combination with an intra-aortic balloon pump or Impella, thereby limiting vascular access options and increasing the risk of vascular complications including bleeding and limb ischemia. For these reasons, new approaches to perform PCI without the need for an additional arterial puncture are required. We describe a case of a 70-year-old man with cardiogenic shock referred for high-risk PCI while supported with VA-ECMO and an Impella CP and illustrate a novel method for single-stick access for PCI through the return cannula of the VA-ECMO circuit.

CONFLICT OF INTEREST

C.S.H., C.D.D., and R.G.: report no conflicts of interest to disclose. N.K.K.: receives consulting/speaker honoraria and research funding from Abbott, Abiomed, Boston Scientific, Medtronic, LivaNova, MD Start, and PreCARDIA.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.